Research findings showed that TSA can act against human pancreatic cancer cell lines by enhancing the expression of pro-apoptotic genes such as the BIM gene, and suppressing the expression of anti-apoptotic genes like Bcl-XL and Bcl-W [91]. This evidence concerns the gene BCL2L11 and pancreatic neoplasm.